Quantifiable MRI aims to pull objectively accurate measurements from a scan copy
Q Bio has launched its Tensor Field Mapping (TFM) technology, which is set to advance insights and diagnostic capabilities in Magnetic Resonance Imaging (MRI). Traditional MRI solutions provide qualitative data prone to machine or clinical variations. Whereas Q Bio’s TFM will present the user with quantitative, harmonised imagining data which AI can access for speedy diagnosis.
“For decades, MRI technology has been invaluable in diagnosing a wide range of medical conditions, yet it has been limited by its qualitative nature and the variability of the data,” said Jeff Kaditz, Founder and CTO / CEO, of Q Bio. “With the introduction of Tensor Field Mapping, we are taking a quantum leap forward, making multi-parametric quantification of tissues reproducible across machines, which is key to AI in MRI and personalised medicine.”
TFM will make its debut in the Mark I fully body scanner. The new technology will allow the user to measure and benchmark the properties of tissues. According to the medical imaging technology specialist, TFM should help promote accurate diagnosis and treatment of diseases, with reliable imagining data now easier to share and compare, regardless of any clinical or machine settings.
“Quantified MRIs have been anticipated for over 25 years, TFM has been the breakthrough that has made them the reality,” said Thomas Witzel, VP of Imaging at Q Bio. “By modelling the entire imaging process without idealising assumptions about the hardware, we're not only enhancing the quality of MRI data but also paving the way for developing new MRI equipment optimised for speed and patient comfort.”
Key features of the TFM:
- 100-fold reduction in computational power.
- Requires a single GPU.
- Imaging harmonisation across software, hardware, and clinical variations, enables knowledge pooling and sharing.
- Enhanced coil sensitivity modelling accuracy with Maxwell regularisation.
- Improved field calibration and motion reconstruction techniques.
“Tensor Field Mapping is more than an innovative technology; it's a vision for the future of medical imaging where frequency, accuracy, and benchmarking with commodity radiomic data is possible,” concluded Clarissa Shen, COO, of Q Bio. “We look forward to sharing our collaborations with healthcare providers and researchers to bring the benefits of TFM to patients around the world.”